Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Free Realtime Quote SEK

Surgical Science Sweden AB (publ) (SUS.ST)

Compare
121.50
+8.60
+(7.62%)
As of 2:25:27 PM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
884,087
884,087
882,853
802,540
366,778
Cost of Revenue
286,189
286,189
269,974
271,023
100,836
Gross Profit
597,898
597,898
612,879
531,517
265,942
Operating Expense
453,576
453,576
423,727
368,980
209,419
Operating Income
144,322
144,322
189,152
162,537
56,523
Net Non Operating Interest Income Expense
13,773
13,773
79,112
45,636
17,546
Pretax Income
158,093
158,093
268,264
208,173
65,804
Tax Provision
26,446
26,446
34,292
20,199
-20,444
Net Income Common Stockholders
131,646
131,646
233,972
187,974
86,248
Diluted NI Available to Com Stockholders
131,646
131,646
233,972
187,974
86,248
Basic EPS
2.58
--
4.59
3.70
2.03
Diluted EPS
2.58
--
4.59
3.69
2.02
Basic Average Shares
51,026.24
--
50,929.36
50,801.24
42,488.25
Diluted Average Shares
51,026.24
--
50,940.78
50,913.94
42,669.28
Total Operating Income as Reported
144,320
144,320
189,152
162,537
56,523
Total Expenses
739,765
739,765
693,701
640,003
310,255
Net Income from Continuing & Discontinued Operation
131,646
131,646
233,972
187,974
86,248
Normalized Income
131,646
131,646
233,972
187,974
86,248
Interest Income
13,773
13,773
79,112
46,941
18,368
Interest Expense
--
--
656
1,305
822
Net Interest Income
13,773
13,773
79,112
45,636
17,546
EBIT
144,322
144,322
189,152
209,478
66,626
EBITDA
144,322
144,322
189,152
261,063
100,143
Reconciled Cost of Revenue
286,189
286,189
269,974
271,023
100,836
Reconciled Depreciation
--
--
55,613
51,585
33,517
Net Income from Continuing Operation Net Minority Interest
131,646
131,646
233,972
187,974
86,248
Normalized EBITDA
144,322
144,322
189,152
261,063
100,143
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 6/19/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers